Physician-led company offers patients choice and convenience through online marketplace
TORONTO – March 11th, 2020: Built by doctors. Made for patients. That’s the philosophy behind a new online service for Canadians in search of enhanced access to medical cannabis. As the first direct-to-sales provider licensed by Health Canada, Cannalogue is an easy-to-use online marketplace for medical cannabis products.
Canadians will no longer need to guess which medical cannabis products or dosages are best for their health conditions. In conjunction with affiliate clinic Oridon Medical, Cannalogue provides a free medical assessment, personalized treatment plan, and the ability to fill prescriptions for medical cannabis, all from the comfort of home. “We know how difficult it can be for patients to access physicians and healthcare practitioners specialized in prescribing medical cannabis – Cannalogue is here to help. Contrary to products currently available to consumers at the recreational level, our medical staff attend to the needs of patients to determine the best treatment plan possible,” says President and CEO, Dr. Mohan Cooray. “Our clinically-focused approach gives patients better control over their health and long-term symptoms.”
Cannalogue’s Amazon-like service offers patients a choice of physician-recommended medical cannabis products. This eliminates the need for repetitive visits to the doctor for modifications to prescriptions. “Patients are no longer confined to a one prescription – one licensed producer system. Patients have choice with Cannalogue,” says Dr. Cooray. “Our products have been carefully selected by physicians based on quality and effectiveness, so patients can simply log in to Cannalogue and choose from a range of licensed producers without the hassle of additional doctor visits,” he says.
For more information or to order medical cannabis online, visit www.cannalogue.ca.
About Cannalogue:
Based in Toronto, Cannalogue is a rapidly-emerging healthcare technology company that received Health Canada’s first direct-to-sales licence. Cannalogue’s innovative technology provides a safe, controlled, and cost-effective online marketplace that is globally scalable into all medical cannabis markets. Engineered by physicians Dr. Mohan Cooray and Dr. Andrew Lu, Cannalogue challenges the status quo and advocates on behalf of patients to educate medical professionals and government officials on the safety and benefits of medical cannabis as a viable treatment option to traditional therapies.